"Low-dose" recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage

Journal of Trauma - Injury, Infection and Critical Care

Volumn 59, Issue 1, 2005, Pages 150-154

  Harrison, T Daniel ^a   Laskosky, Jason ^a   Jazaeri, Omid ^a   Pasquale, Michael D ^a   Cipolle, Mark ^a  

^a LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

Blood product use; Blunt trauma; Recombinant activated factor VII; Traumatic hemorrhage

Indexed keywords

FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOCYTE CONCENTRATE;

ADULT; ALGORITHM; BLEEDING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CRYOPRECIPITATE; DISEASE SEVERITY; ERYTHROCYTE CONCENTRATE; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MORTALITY; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; THROMBOCYTE; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ADULT; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FACTOR VII; FACTOR VIIA; FEMALE; HEMORRHAGE; HUMANS; INJURY SEVERITY SCORE; INTERNATIONAL NORMALIZED RATIO; MALE; RECOMBINANT PROTEINS; REGISTRIES; TREATMENT OUTCOME; WOUNDS, NONPENETRATING;

EID: 24644498683     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000171470.39742.8E     Document Type: Review

References (19)

1. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995;38:185-193.
2. Moore EE. Thomas G. Orr Memorial Lecture: staged laparotomy for the hypothermia, acidosis, and coagulopathy syndrome. Am J Surg. 1996;172:405-410.
3. Anantharaju A, Mehta K, Mindikoglu AL, et al. Use of activated recombinant human factor VII for colonic polypectomies in patients with cirrhosis and coagulopathy. Dig Dis Sci. 2003;48:1414-1424.
4. Friederich PW, Henny CP, Messelink EJ, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind, placebo-controlled randomised trial. Lancet. 2003;361:201-205.
5. Tanaka KA, Waly AA, Cooper WA, et al. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven). Anesthesiology. 2003;98:1513-1515.
6. Wahlgren CM, Swedenborg J. The use of recombinant activated factor VII to control bleeding during repair of a suprarenal abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2003;26:221-222.
7. Kenet G, Walden R, Eldad A, Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa [letter]. Lancet. 1999;354:1879.
8. O'Neill PA, Bluth M, Gloster ES, et al. Successful use of recombinant activated factor VII for trauma-associated hemorrhage in a patient without preexisting coagulopathy. J Trauma. 2002;52:400-405.
9. Dutton RP, Hess JR, Scalea TM. Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients. J Clin Anesth. 2003;15:184-188.
10. Martinowitz U, Kenet G, Segal E, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma. 2001;51:431-439.
11. Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol. 1997;99:542-547.
12. Meng ZH, Wolberg AS, Monroe DM III, Hoffman M. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma. 2003;55:886-891.
13. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288:1499-1507.
14. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT study: anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med. 2004;32:39-52.
15. Davis JW, Parks SN, Kaups KL, Gladen HE, O'Donnell-Nicol S. Admission base deficit predicts transfusion requirements and risk of complications. J Trauma. 1996;41:769-774.
16. Asensio JA, McDuffie L, Petone P, et al. Reliable variables in the exsanguinated patient which indicate damage control and predict outcome. Am J Surg. 2001;182:743-751.
17. Cipolle MD, Wojcik R, Seislove E, Wasser TE, Pasquale MD. The role of surveillance duplex scanning in preventing venous thromboembolism in trauma patients. J. Trauma. 2002;52:453-462.
18. Taylor RW, Manganaro L, O'Brien J, et al. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med. 2002;30:2249-2254.
19. Erhardtsen E. Ongoing NovoSeven trials. Intensive Care Med. 2002;28:5248-5255.